RxSight, Inc. RXST Net proceeds from sales of subsidiary shares
Net proceeds from sales of subsidiary shares at other companies
Other financials
Where this comes from
Reported directly by RxSight, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceInitialPublicOffering.
The official record: RxSight, Inc.’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →
Ask your AI about RxSight, Inc.'s net proceeds from sales of subsidiary shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is RxSight, Inc.'s net proceeds from sales of subsidiary shares?
- RxSight, Inc. (RXST) reported net proceeds from sales of subsidiary shares of $0 in Q4 2025.
- What does net proceeds from sales of subsidiary shares mean?
- This represents the net cash proceeds received by the company from the sale of equity shares to the public during an initial public offering or subsequent equity issuance. It highlights the company's ability to raise capital from public markets to fund growth, research, or operational expansion. This metric is a primary indicator of investor confidence and the company's access to equity financing.